/Lists

Biotech Growth Investors & VC Firms

708 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.

Arkin Capital
HerzliyaSeed–Late Stage
28 people
1315 Capital
PhiladelphiaGrowth$5M – $40M
20 people
Sampac Tech Fund
Palo AltoSeed–Late Stage
31 people
Scientifica Venture Capital
Pre-Seed–Growth
28 people
Oregon Venture Fund
PortlandPre-Seed–Growth$500K – $5M
9 people
K3 Ventures
SingaporeSeed–Growth
20 people
Georgian
Toronto, OntarioSeries C–Growth$25M – $100M
18 people
Panacea Venture
SingaporeSeed–Late Stage
22 people
BPOC
ChicagoGrowth$25M – $100M
23 people
K2 HealthVentures
BostonGrowth–Late Stage
22 people
Signet Healthcare Partners
New YorkGrowth$10M – $50M
13 people
Dentsu Ventures
TokyoSeed–Late Stage
12 people
Catalyst Investments, L.P.
Tel AvivGrowth–Late Stage$1.5M – $5M
29 people
Cenova Capital
ShanghaiGrowth–Late Stage
22 people
FIMI Opportunity Funds
Tel AvivGrowth
2 people
RBCx
TorontoPre-Seed–Growth
18 people
Remgro / Invenfin ecosystem
StellenboschSeed–Growth
21 people
Windham Capital Partners
New YorkSeries A–Growth$1M – $5M
17 people
Mitsui Global Investment
Menlo ParkPre-Seed–Late Stage$500K – $10M
12 people
European Circular Bioeconomy Fund
BonnSeries A–Growth$5.5M – $16.5M
23 people
Magna Investment
SeoulSeed–Growth
17 people
PortfoLion Capital Partners
BudapestSeed–Growth$540K – $32.4M
31 people
Xeraya Capital
Kuala LumpurSeed–Growth
22 people
Domain Associates
PrincetonSeed–Growth$200K – $15M
11 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.